Skip to Main Content

Good morning, everyone, and how are you today? Another busy day is unfolding here on the Pharmalot campus, where we are mulling over our cluttered calendar and plotting our next moves. No doubt, you can relate. After all, this is only the middle of the week and there is so much to be done. This calls, as you may imagine, for a hot cup of stimulation — Pumpkin Spice is our enjoyable choice. Feel free to join us. Meanwhile, here are some tidbits. Hope you make your way today. …

Vaccine makers are pushing the European Union for certain liability protections, The Financial Times reports. This would include a “comprehensive no-fault and non-adversarial compensation system, and an exemption from civil liability” if there are problems with the Covid-19 vaccines, “in order to compensate for such high risks taken by manufacturers.” Last month, AstraZeneca (AZN) secured partial exemption from future product liability claims on its vaccine candidate, which it is developing in partnership with the University of Oxford.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!